BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3505841)

  • 21. Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrations.
    Godley PJ; Ludden TM; Clementi WA; Godley SE; Ramsey RR
    Clin Pharm; 1987 Aug; 6(8):634-9. PubMed ID: 3691009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a Bayesian regression-analysis computer program for predicting phenytoin concentration.
    Ludden TM; Beal SL; Peck CC; Godley PJ
    Clin Pharm; 1986 Jul; 5(7):580-5. PubMed ID: 3755661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin monitoring: one or two serum levels?
    Andrés I; López R; Pou L; Piñol F; Pascual C
    Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
    Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
    Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methods.
    Lalonde RL; Pao D
    Clin Pharm; 1984; 3(2):178-83. PubMed ID: 6723224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple method to estimate the initial dose of gentamicin.
    Lackner TE; Lyss AP
    Pharmacotherapy; 1992; 12(3):195-200. PubMed ID: 1608852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of gentamicin. Estimation of initial dosing parameters in hospitalized patients at Al-Amiri Hospital Kuwait.
    Al-Lanqawi Y; Capps P; Abudlmalek K; Al-Anezi K; Thusu A; Sharma P
    Med Princ Pract; 2009; 18(3):209-16. PubMed ID: 19349724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomogram for dosing warfarin at steady state.
    Fredriks DA; Coleman RW
    Clin Pharm; 1991 Dec; 10(12):923-7. PubMed ID: 1773579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
    Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
    Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T; Coleman R; Ludden T; Peck CC; Rose D
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.
    Lee C; Coleman RW; Mungall DR
    Clin Pharm; 1987 May; 6(5):406-12. PubMed ID: 3665392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical assessment of a two-compartment Bayesian forecasting method for lidocaine.
    Beach CL; Farringer JA; Peck CC; Crawford MH; Ludden TM; Clementi WA
    Ther Drug Monit; 1988; 10(1):74-9. PubMed ID: 3376185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.